HK1164767A1 - Compounds and methods for the treatment of cancer - Google Patents
Compounds and methods for the treatment of cancerInfo
- Publication number
- HK1164767A1 HK1164767A1 HK12105772.9A HK12105772A HK1164767A1 HK 1164767 A1 HK1164767 A1 HK 1164767A1 HK 12105772 A HK12105772 A HK 12105772A HK 1164767 A1 HK1164767 A1 HK 1164767A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- cancer
- compounds
- treatment
- methods
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/285—Arsenic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/66—Arsenic compounds
- C07F9/70—Organo-arsenic compounds
- C07F9/72—Aliphatic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70416305P | 2005-07-29 | 2005-07-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1164767A1 true HK1164767A1 (en) | 2012-09-28 |
Family
ID=37809342
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK08112236.1A HK1117780A1 (en) | 2005-07-29 | 2008-11-07 | Compounds and methods for the treatment of cancer |
| HK12105772.9A HK1164767A1 (en) | 2005-07-29 | 2008-11-07 | Compounds and methods for the treatment of cancer |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK08112236.1A HK1117780A1 (en) | 2005-07-29 | 2008-11-07 | Compounds and methods for the treatment of cancer |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US7968738B2 (ja) |
| EP (2) | EP1919564B1 (ja) |
| JP (1) | JP4994374B2 (ja) |
| AU (1) | AU2006285329B2 (ja) |
| CA (1) | CA2617049A1 (ja) |
| ES (2) | ES2531159T3 (ja) |
| HK (2) | HK1117780A1 (ja) |
| NO (1) | NO20081045L (ja) |
| WO (1) | WO2007027344A2 (ja) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007027344A2 (en) | 2005-07-29 | 2007-03-08 | Ziopharm Oncology, Inc. | Compounds and methods for the treatment of cancer |
| TW200829261A (en) | 2006-09-29 | 2008-07-16 | Ziopharm Oncology Inc | Method for controlling angiogenesis in animals |
| ES2392737T3 (es) * | 2007-11-02 | 2012-12-13 | Ziopharm Oncology, Inc. | Terapia combinada con compuestos arsenicales orgánicos |
| CN101874034A (zh) * | 2007-12-12 | 2010-10-27 | Zio医药肿瘤学公司 | 用于治疗癌症的化合物和方法 |
| DK2321012T3 (en) | 2008-08-20 | 2018-12-03 | Solasia Pharma K K | ORGANIC RELATIONS AND PROCEDURES FOR TREATING CANCER |
| EP2897906B1 (en) | 2012-09-20 | 2017-07-05 | Bendale, Yogesh Narayan | Process for bio synthesis of nano arsenic trioxide and its use in treatment of diseases including cancers |
| US20160304546A1 (en) * | 2013-12-05 | 2016-10-20 | Solasia Pharma K.K. | Compounds and methods for the treatment of cancer |
| BR112017018772B1 (pt) * | 2015-03-12 | 2021-09-21 | Km Biologics Co., Ltd. | Material antiadesão, método para a preparação e kit do referido material e biomembrana substituta, método para a preparação e kit da referida membrana |
| CN107167433A (zh) * | 2016-03-07 | 2017-09-15 | 天津国际生物医药联合研究院 | 一种检测氯二甲基砷的方法 |
| JPWO2019220961A1 (ja) * | 2018-05-18 | 2020-05-28 | ソレイジア・ファーマ株式会社 | ダリナパルシンのアルカリ金属塩及び／又は無機酸付加塩の結晶型及びその製剤 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6277819B1 (en) * | 1996-08-30 | 2001-08-21 | Eli Lilly And Company | Use of GLP-1 or analogs in treatment of myocardial infarction |
| AU751932B2 (en) * | 1997-10-15 | 2002-08-29 | Polarx Biopharmaceuticals, Inc. | Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| PT1964557E (pt) * | 1997-11-10 | 2013-02-20 | Sloan Kettering Inst Cancer | Processo para a produção de formulações de trióxido de arsénio |
| EP1049486A4 (en) * | 1997-12-05 | 2006-01-04 | Lilly Co Eli | GLP-1 FORMULATIONS |
| CN1233476A (zh) * | 1998-04-24 | 1999-11-03 | 陆道培 | 治疗急性白血病的药物及其制备方法 |
| SE9802080D0 (sv) * | 1998-06-11 | 1998-06-11 | Hellstroem | Pharmaceutical composition for the treatment of functional dyspepsia and/or irritable bowel syndrome and new use of substances therein |
| EP1002537A1 (en) | 1998-10-30 | 2000-05-24 | Assistance Publique, Hopitaux De Paris | Use of melarsoprol for the manufacture of a medicament for treating B-cell lymphoproliferative diseases, such as multiple myeloma |
| US6191123B1 (en) * | 1999-03-19 | 2001-02-20 | Parker Hughes Institute | Organic-arsenic compounds |
| AU5391901A (en) * | 2000-04-26 | 2001-11-07 | Univ Oregon Health Sciences | Administration of a thiol-based chemoprotectant compound |
| EP2420229A1 (en) * | 2002-01-07 | 2012-02-22 | Board Of Regents, University Of Texas System | S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer |
| TW201440760A (zh) | 2004-07-16 | 2014-11-01 | Texas A & M Univ Sys | 有機砷化合物、其用於治療癌症之用途及包含其之醫藥組成物 |
| WO2007027344A2 (en) | 2005-07-29 | 2007-03-08 | Ziopharm Oncology, Inc. | Compounds and methods for the treatment of cancer |
| ES2392737T3 (es) * | 2007-11-02 | 2012-12-13 | Ziopharm Oncology, Inc. | Terapia combinada con compuestos arsenicales orgánicos |
-
2006
- 2006-07-28 WO PCT/US2006/029835 patent/WO2007027344A2/en active Application Filing
- 2006-07-28 JP JP2008524273A patent/JP4994374B2/ja active Active
- 2006-07-28 AU AU2006285329A patent/AU2006285329B2/en not_active Ceased
- 2006-07-28 EP EP06824793.1A patent/EP1919564B1/en active Active
- 2006-07-28 US US11/495,172 patent/US7968738B2/en active Active
- 2006-07-28 CA CA002617049A patent/CA2617049A1/en not_active Abandoned
- 2006-07-28 ES ES06824793T patent/ES2531159T3/es active Active
- 2006-07-28 EP EP11180330.0A patent/EP2394702B1/en not_active Not-in-force
- 2006-07-28 ES ES11180330.0T patent/ES2532666T3/es active Active
-
2008
- 2008-02-28 NO NO20081045A patent/NO20081045L/no not_active Application Discontinuation
- 2008-11-07 HK HK08112236.1A patent/HK1117780A1/xx unknown
- 2008-11-07 HK HK12105772.9A patent/HK1164767A1/xx unknown
-
2011
- 2011-06-01 US US13/150,516 patent/US8334398B2/en active Active
-
2012
- 2012-11-14 US US13/676,929 patent/US8865764B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2531159T3 (es) | 2015-03-11 |
| EP1919564B1 (en) | 2014-11-26 |
| JP4994374B2 (ja) | 2012-08-08 |
| WO2007027344A2 (en) | 2007-03-08 |
| US8334398B2 (en) | 2012-12-18 |
| ES2532666T3 (es) | 2015-03-30 |
| CA2617049A1 (en) | 2007-03-08 |
| HK1117780A1 (en) | 2009-01-23 |
| EP1919564A2 (en) | 2008-05-14 |
| US8865764B2 (en) | 2014-10-21 |
| AU2006285329A2 (en) | 2008-08-14 |
| US20070183972A1 (en) | 2007-08-09 |
| WO2007027344A3 (en) | 2007-12-21 |
| US20130142730A1 (en) | 2013-06-06 |
| US7968738B2 (en) | 2011-06-28 |
| US20120022229A1 (en) | 2012-01-26 |
| EP2394702A1 (en) | 2011-12-14 |
| NO20081045L (no) | 2008-04-25 |
| AU2006285329B2 (en) | 2012-10-04 |
| EP2394702B1 (en) | 2014-12-31 |
| JP2009502971A (ja) | 2009-01-29 |
| AU2006285329A1 (en) | 2007-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL188746A0 (en) | Treatment of cancer | |
| HK1204476A1 (en) | Compounds and methods for treatment of cancer | |
| IL191832A0 (en) | Pyridiazinone derivatives for the treatment of tumours | |
| IL188430A0 (en) | Treatment of tumors | |
| IL227841A0 (en) | Dihydropyridinones for the treatment of cancer | |
| HK1117780A1 (en) | Compounds and methods for the treatment of cancer | |
| EP2049151A4 (en) | METHOD AND COMPOSITIONS FOR THE TREATMENT OF CANCER | |
| AU2006251167A8 (en) | Tetrahydropyridothiophenes for use in the treatment of cancer | |
| AU2006251169A8 (en) | Tetrahydropyridothiophenes for use in the treatment of cancer | |
| EP1867640A4 (en) | MEANS FOR TREATING SOLID TUMORS | |
| GB0517387D0 (en) | Combinations for the treatment of cancer | |
| EP1904088A4 (en) | COMPOSITIONS AND METHODS FOR TREATING CANCER | |
| IL187792A0 (en) | 4-anilino-3-quinolinecarbonitriles for the treatment of cancer | |
| IL226363A0 (en) | Compounds and methods for treating cancer | |
| GB0520067D0 (en) | Treatment of cancer | |
| EP1797430A4 (en) | METHOD AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF CANCER | |
| ZA200805522B (en) | Dioxoiane dérivates for the treatment of cancer | |
| HK1209754A1 (en) | Compounds and methods for the treatment of cancer | |
| GB0507685D0 (en) | Cancer treatment | |
| GB0410379D0 (en) | Treatment of cancer | |
| GB0517386D0 (en) | Combinations for the treatment of cancer | |
| GB0423273D0 (en) | Treatment of cancer | |
| GB0507785D0 (en) | Treatment of cancer | |
| ZA200700845B (en) | Treatment of cancer | |
| GB0421734D0 (en) | Treatment of cancer |